Affinage mechanistic annotation for ACTR1B (human) Affinage Affinage (Claude Sonnet reading pass + Opus synthesis pass) 4 citations

Affinage mechanistic annotation for ACTR1B (human)

Current model (mechanistic narrative)

ACTR1B (beta-centractin) is an actin-related protein that functions as a stoichiometric minor subunit of the cytosolic 20S dynactin complex PMID:7696711. It partitions predominantly to the cytosolic fraction with no detectable free pool, residing within dynactin at a fixed ratio of approximately 1:15 relative to alpha-centractin, which establishes its identity as a constitutive structural component of this complex rather than an independently acting protein PMID:7696711. Beyond its membership in dynactin, ACTR1B abundance is modulated in a cell-type-specific manner: it is differentially altered in human platelets upon glycoprotein VI activation PMID:20107233 and down-regulated in dendritic cells pulsed with high-metastatic-potential hepatocellular carcinoma lysates, where its reduction tracks with diminished CD86 expression and impaired allostimulatory capacity [PMID:17619203, PMID:17925177]. No direct functional dissection of ACTR1B's role within dynactin or in these cellular contexts has been characterized in the available corpus.

Affinage mechanism profile (Affinage's own GO/Reactome grounding)

Dated findings (citation-anchored)

Year Confidence Finding PMIDs Journal
1994 High Beta-centractin (ACTR1B) is an actin-related protein that localizes predominantly to the cytosolic fraction as a component of the 20S dynactin complex, with no evidence for a free pool; it exists in a constant ratio of approximately 1:15 (beta:alpha) relative to alpha-centractin within the dynactin complex. PMID:7696711 Molecular biology of the cell
2010 Low Beta-centractin (ACTR1B) protein abundance is differentially altered in human platelets upon specific activation of glycoprotein VI (GPVI), indicating that GPVI signaling modulates beta-centractin levels and cytoskeletal organization in platelets. PMID:20107233 Blood
2007 Low Down-regulation of beta-centractin in dendritic cells pulsed with high-metastatic-potential HCC cell lysates is associated with reduced CD86 expression and impaired allostimulatory capacity (mixed lymphocyte reaction), suggesting beta-centractin supports normal DC function. PMID:17619203, PMID:17925177 Journal of cancer research and clinical oncology

Citations